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A myriad of ophthalmic disorders is associated with the phenotype of Down syndrome including strabismus, cataracts, and
refractive errors potentially resulting in signiﬁcant visual impairment. Ophthalmic sequelae have been extensively studied in
children and adolescents with Down syndrome but less often in older adults. In-depth review of medical records of older adults
with Down syndrome indicated that ophthalmic disorders were common. Cataracts were the most frequent ophthalmic disorder
reported, followed by refractive errors, strabismus, and presbyopia. Severity of intellectual disability was unrelated to the presence
ofophthalmicdisorders.Also,ophthalmicdisorderswereassociatedwithlowervision-dependentfunctionalandcognitiveabilities,
although not to the extent that was expected. The high prevalence of ophthalmic disorders highlights the need for periodic
evaluations and individualized treatment plans for adults with Down syndrome, in general, but especially when concerns are
identiﬁed.
1. Ophthalmic DisordersinAdults with
DownSyndrome
Down syndrome is the most prevalent genetic disorder asso-
ciated with intellectual disability and is due to the presence
of complete or partial triplication of chromosome 21 [1].
It is associated with a characteristic physical and cognitive
phenotype, although almost every aspect of the phenotype
shows variability in terms of occurrence and severity [2, 3].
Down syndrome carries with it an increased risk of congeni-
tal heart defects, hearing loss, autoimmune diseases, short-
ened life expectancy, early onset Alzheimer’s disease, and
other concerns related to health and aging that also
include multiple ophthalmic disorders [4–7]. Earlier studies
have indicated increased risk for abnormality in virtually
all structures of the eye including the lid, iris, cornea, lens,
and retina [8–11]. As a consequence, nystagmus, strabismus,
keratoconus, amblyopia, cataracts,a n drefractive errors are
prevalent in this population potentially resulting in signif-
icant visual impairment [12, 13] (see Appendix for brief
deﬁnitions of italicized terms). While no speciﬁc ophthalmic
disorder seems to be pathognomonic of Down syndrome,
many individuals present with a combination of conditions
[12, 14].
The ophthalmic sequelae in children and adolescents
with Down syndrome have received considerable attention
[12, 15–18], but the prevalence of vision problems in older
adults has been reported less often. The life expectancy
of adults with Down syndrome has increased dramatically
over the last several decades [19, 20]a n da sac o n s e q u e n c e ,
they are prone to experience health problems associated
with advancing age, such as visual functioning deﬁcits that
are likely to be similar to or more severe than those seen
in adults without intellectual disability. The studies that do
exist on vision in adults with Down syndrome have generally
found that the number and severity of ophthalmic disorders2 Current Gerontology and Geriatrics Research
increase with age [9, 21–27]. Van Schrojenstein Lantman-de
Valk et al. [23] examined the sensory functioning of older
individuals with intellectual disability in the Netherlands,
who were between 50 and 59 years of age and found that
visual impairment occurred in 46% of adults with Down
syndrome. This number increased signiﬁcantly with age
such that 85% of people with Down syndrome, 60 years of
age and older, experienced visual impairment [9, 21, 27].
The age-speciﬁc prevalence for speciﬁc ophthalmic disorders
has rarely been reported [28] although van Schrojenstein
Lantman de Valk et al. [23] found that the prevalence of
cataracts in adults with Down syndrome increased from
16% of individuals between 50 and 59 years of age to
63% of individuals 60 years of age and older (also see
[29]). Van Buggenhout et al. [27] found that the severity
of ophthalmic disorders increased with age in adults with
Down syndrome. While moderate-to-severe vision loss was
reported in 18% of individuals between 30 and 39 years of
age, prevalence increased to 28% for individuals between
40 and 49 years of age and to almost 50% for individ-
uals between 50 and 59 years of age. Thus, it is likely
that changes in vision are among the features of atypical
aging seen in individuals with Down syndrome in middle
age.
Prevalence of ophthalmic disorders has been found to
increase dramatically with severity of intellectual impair-
ment in individuals with Down syndrome ([9, 30]; cf. [15]).
For example, Evenhuis et al. [9] observed visual impairment
in 4.5% of individuals with mild or moderate intellectual
disability but in 74% of individuals with severe or profound
intellectual disability. Several researchers examined the rela-
tion between severity of intellectual disability and prevalence
of speciﬁc disorders [10, 31, 32]. McCulloch et al. [31]f o u n d
that 25% of individuals with mild intellectual disability had
strabismus compared to 60% of individuals with profound
intellectual disability. Further, esotropia (the form of stra-
bismus where one or both eyes tend to drift inward) was
typically found in those with milder disabilities, whereas
exotropia (where one or both eyes tend to drift outward) was
most common in those with more severe disabilities [31].
Other associations with severity of intellectual impairment
have been found for visual acuity as well as refractive errors
[31, 32].
Intellectual disability results in signiﬁcantly impaired
functioning, but when it cooccurs with visual impairment,
overall disability can be exacerbated and quality of life
may be reduced. Visual impairment has been found to
signiﬁcantly decrease independent living skills, communi-
cation and language skills, social skills, and initiative and
persistence [33, 34]. The aim of the present study was
to evaluate the characteristics and prevalence of speciﬁc
ophthalmic disorders in older adults with Down syndrome
(from 30 to 83 year olds) and to determine if the pres-
ence of ophthalmic disorders aﬀects adaptive behavior
and cognitive status. In addition, inclusion of individuals
with a wide range of intellectual disability (FSIQ range
= 20–71) enabled the examination of how prevalence of
ophthalmic disorders varies as a function of intellectual
disability.
Table 1: Participant characteristics.
Characteristic Down syndrome (n = 455)
Age (Mean, SD) (50.93, 7.85)
Computed FSIQ1 (Mean, SD) (32.49, 9.37)
n %
Age group
30–39 23 5.1
40–49 188 41.3
50–59 184 40.4
60–69 50 11.0
70–79 9 2.0
80+ 1 .2
Level of intellectual disability
Mild 30 6.9
Moderate 167 38.3
Severe 114 26.1
Profound 125 28.7
Sex
Female 316 69.5
Male 139 30.5
Presence of ophthalmic disorders 353 77.6
1IQs were unavailable for 19 adults (4.2%).
2. Method
2.1. Human Subject Approvals. This study was approved
by the Institutional Review Boards of the New York State
Institute for Basic Research in Developmental Disabilities
and the Johns Hopkins University School of Medicine.
Participants gave their assent for all procedures, and for each
participant, an authorized representative provided informed
consent.
2.2. Participants. The participants were 455 adults with
Down syndrome, who were enrolled in a larger multidisci-
plinary study focused on aging and dementia (see [35, 36]
for inclusion criteria). Table 1 presents the demographic
characteristics of the participants. There was a preponder-
ance of females (69.5%), which reﬂects the interests and
sampling procedures of our overall program, one goal of
which was to investigate women’s health issues and aging.
Multiple IQs were obtained from clinical records and testing
typically occurred when the participants were children or
young adults. The speciﬁc IQ tests and dates of adminis-
tration were also recorded. We generated a “consensus Full
Scale/Composite IQ” for each participant using either the
results actually obtained or, in cases where data were only
available from the Wechsler Adult Intelligence Scale [37],
an estimated “Stanford-Binet-equivalent” was calculated to
address the compelling evidence that the various editions of
the Wechsler Adult Intelligence Scale generate substantially
higher IQs for this population compared to other assess-
ments [38].
Down syndrome was conﬁrmed cytogenetically for 368
(82.9%) individuals; 328 (89.1%) had full trisomy 21, 25
(6.8%) had trisomy 21 mosaicism, and 15 (4.1%) had anCurrent Gerontology and Geriatrics Research 3
autosomal translocation. The families of 76 (16.7%) indi-
viduals refused consent for a blood sample, and we were
unable to obtain a blood sample from another 12 individuals
(2.6%). These 88 individuals were conﬁrmed to have trisomy
21 based on phenotype.
2.3. Materials and Procedures. Participants were comprehen-
sively evaluated at approximately 18-month intervals with an
assessment battery that included detailed review of medical
records, informant interviews, direct assessment of a variety
of cognitive functions, collection of blood samples, and,
for a selected subsample, a neurological examination. The
primary data for this study came from the medical records
of participants obtained from clinical or agency ﬁles and
examinedupontheirentryintothestudy.Theserecordswere
hand-searchedanddataregardingalldiagnosesandclinically
signiﬁcant health problems were extracted and entered onto
a standardized form following a protocol developed in
conjunction with the broader research program. The form
included questions pertaining to all body systems. It also
included the date and course of treatment for speciﬁc con-
ditions and demographic information. The presence or ab-
sence of speciﬁc ophthalmic disorders was examined for this
report.
As part of our longitudinal study, we examined the cog-
nitive abilities and behavioral functioning of all study partic-
ipants. For the current study, we report on measures where
performance should be especially sensitive to visual pro-
cessing and, for comparison, those that should be relatively
independent of visual processing. The medical chart review,
cognitive, and adaptive measures were collected contempo-
raneously. The American Association on Mental Retardation
(AAMR)—Adaptive Behavior Scale (ABS-Part One) [39,
40], an informant-based assessment measuring a variety of
functional domains, was used to examine adaptive compe-
tence and functional abilities. The skills examined within
Part One are grouped into 10 behavior domains reﬂect-
ing independent functioning, physical development, eco-
nomic activity, language development, numbers and time,
domestic activity, vocational activity, self-direction, respon-
sibility, and socialization. The 10 adaptive domain scores
weresummedtocreateanoverallindexofadaptivefunction-
ing with a maximum possible score of 280.
The cognitive abilities of participants were evaluated
with direct testing. Measures sensitive to visual processing
included the Block Design subtest of the WISC-R [41]p l u s
a series of simpler items referred to as the Extended Block
Design test [42]. Both tasks involved reproducing visual
patterns from models with red and white Kohs blocks. These
tests provided a measure of visuospatial organization, with
performance requiring both an analysis of visual details
and the synthesis of the ﬁnal design. Procedures were
consistent with those described in the WISC-R manual
with the exception that testing always began with the
simplestdesign,asingleblock,andprogressedindiﬃcultyto
2 × 2- and 3 × 3-block designs. Each trial had a time limit,
and the score represents the number of designs completed
successfully within that time frame. The dependent measure
wasthesumoftherawscoresonthesetwotests(scaledscores
were unavailable for the ages of our participants), with a
maximum possible score of 78.
The Beery-Buktenica Developmental Test of Visual-
Motor Integration was used to ascertain construction ability
[43]. The task requires participants to copy simple ﬁgures
using paper and pencil, starting with one straight line (in
both a horizontal and vertical orientation) and a circle.
Figures progressively increase in complexity by the addition
of lines and shapes. A single summary score was generated
to reﬂect overall performance using standard scoring proce-
dures with a maximum possible score of 27.
An adaptation of the McCarthy [44] Verbal Fluency Test
was one of the “nonvisual” tasks included in our battery.
It requires participants to name as many foods, animals, or
clothes (two of these categories are administered in any given
test cycle) as fast as possible within 20s. A summary score
was generated by adding the number of correct responses for
the two categories.
Another test independent of visual processing was a
modiﬁed version of the Selective Reminding Test [45, 46].
Eight items from a single semantic category (animals or
foods)arepresentedverballyfollowedby6trialsoffreerecall.
After the ﬁrst trial, only those items that were not recalled on
an immediately preceding trial are represented for learning
on the next trial. The Selective Reminding Test generates
multiple scores that reﬂect the eﬃciency of various memory
processes [45, 47], but our primary measure of interest was
the total number of items recalled over the 6 trials with a
maximum score of 48.
SYSTAT 12 was used for all analyses. Chi-square analyses
were conducted on categorical data. Graphic analyses were
conducted on these data to determine overall signiﬁcance for
the set of dependent variables following procedures similar
to those described by Schweder and Spjøtvoll [48]. This
strategy avoids the substantial loss of power associated with
a straightforward Bonferroni correction for multiple tests
yet addresses concerns associated with potential inﬂation of
type-I error probability. The General Linear Model module
was used for analyses of continuous data.
3. Results
It was exceedingly common for older adults with Down
syndrome to have an ophthalmic disorder. The medical
records of 77.6% (353 of 455) adults with Down syndrome
indicated they had at least one ophthalmic disorder. We
f o u n da na s s o c i a t i o nb e t w e e na g ea n dt h ep r e v a l e n c eo f
havingatleastoneophthalmicdisordersuchthat,asagroup,
individuals having an ophthalmic disorder were 2.5 years
olderthanthosewhodidnot,F (1,454) =8.35,P = .004.The
association between sex and the prevalence of having at least
one ophthalmic disorder was not signiﬁcant, χ2 (1, N = 455)
< 1.
Data regarding the prevalence of speciﬁc ophthalmic
disorders are summarized in Table 2.Aw i d ev a r i e t yo f
ophthalmic disorders was noted in participants’ medical
charts.4 Current Gerontology and Geriatrics Research
Table 2: Common ophthalmic ﬁndings and percentage prevalence.
Ophthalmic conditions
Amblyopia 13 (2.9%)
Aphakia 13 (2.9%)
Blepharitis 46 (10.1%)
Legal blindness 35 (7.7%)
Cataracts 191 (42.0%)
Conjunctivitis 61 (13.4%)
Diabetic retinopathy 0
Dry eye 4( . 9 % )
Glaucoma 9 (2.0%)
Keratoconus 13(2.9%)
Macular degeneration 8 (1.8%)
Nystagmus 16 (3.5%)
Presbyopia/hyperopia 57 (12.5%)
Pseudoaphakia 11 (2.4%)
Pterygium 10 (2.2%)
Ptosis 3( . 7 % )
Refractive error 115 (25.3%)
Astigmatism 52 (11.4%)
Myopia 88 (19.3%)
Retinal detachment 2( . 4 % )
Retinitis pigmentosa 1( . 2 % )
Strabismus 96 (21.1%)
Esotropia 79 (17.4%)
Exotropia 2 (.4%)
Cataracts were the most frequent ophthalmic disorder
reported for adults with Down syndrome, aﬀecting 191 of
455 (42%) individuals. Refractive errors were the second
most frequent disorder, reported for 115 adults (25%), with
astigmatism and myopia as the leading causes. Strabismus
was reported in 21.1% and presbyopia in 12.5% of adults
with Down syndrome. Legal blindness was reported in 7.7%
of adults with Down syndrome. Keratoconus and nystagmus
have been reported in previous studies as conditions fre-
quently causing visual impairment in individuals with Down
syndrome but were only noted in 2.9% and 3.5% of individ-
uals in our study, respectively. Blepharitis and conjunctivitis,
two inﬂammatory conditions of the eye that are unrelated
to visual impairment, were reported for 10.1% and 13.4%
of our sample, respectively. All other eye conditions were
reported in small numbers.
Several disorders showed an association with age.
Cataracts were more common for the older individuals, F
(1,453) = 24.83, P<. 001, while astigmatism, F (1,453) =
13.16, P<. 001 and refractive errors, F (1,453) = 12.05, P<
.001 were more frequently reported for younger individuals.
The presence of all other ophthalmic disorders were found to
be unrelated to age.
3.1. The Prevalence of Ophthalmic Disorders and the Severity
of Intellectual Disability. Overall, the prevalence of having at
Table 3: Age-related prevalence of cataracts.
Age
(years)
Down
syndrome (%)
General population in United States
without intellectual disability1
30–39 13.0% —2
40–49 37.8% 2.5%
50–59 42.9% 6.8%
60–69 60.0% 20.0%
70–79 77.8% 42.8%
80+ 100.0%3 68.3%
1The Eye Diseases Prevalence Research Group (2004a) [49] and summary
data available at: http://nei.nih.gov/eyedata/pbd tables.asp.
2Data unavailable.
3Only one participant in this age category.
least one ophthalmic disorder was not signiﬁcantly diﬀerent
among intellectual disability severity groups for adults with
Down syndrome. With one exception, this was also our
ﬁnding for speciﬁc ophthalmic conditions. Individuals who
were legally blind were more likely to have profound intel-
lectual impairment (24 out of 33 legally blind participants)
compared to their peers who were not legally blind, χ2 (3,
N = 436) = 34.11, P<. 001.
3.2. Cataracts. Because prevalence of cataracts was high, we
examined cumulative incidence by age and treatment plans
for individuals with this condition. Two individuals had
congenital cataracts. Congenital cataracts are considered to
be a distinct phenomenon, and the two aﬀected individuals
were, therefore, excluded from these analyses.
The average age in which an individual with Down syn-
drome was diagnosed with cataracts was 48.43 years (SD =
9.87). Prevalence of cataracts was unrelated to intellectual
disability severity, but was related to age, as discussed pre-
viously. Table 3 presents summary prevalence data for each
10-year age interval for individuals with Down syndrome
and the US national estimates forthe generalpopulation (see
[49]).Clearly,prevalenceishigherforadultswithDownsyn-
drome, who are in their 40s through 60s, χ2 (2, N = 455) =
1246, P<. 10
−6.
A reconstructed cohort design [50]w a su s e dt oe s t i m a t e
cumulative incidence of cataracts, in which each participant
was considered to be at risk from birth until their current
age (if unaﬀected) or until the age at which they received
a diagnosis. A Kaplan-Meier Survival Analysis was used to
estimate time-to-diagnosis. Figure 1 clearly shows that risk
for individuals with Down syndrome increased with age
quite rapidly beginning at approximately 40 years of age.
3.2.1. Treatment Plans. An u m b e ro ft r e a t m e n to p t i o n sw e r e
prescribed, typically dependent on the resulting degree of
vision loss experienced by an individual. The most fre-
quent treatments included: (a) surgery with intraocular lens
implantation, (b) an increase in prescription strength of
glasses, or (c) surveillance for increasing vision loss.
For almost half of the individuals with diagnosed
cataracts, no treatment was undertaken at the time of diag-
nosis(45.3%).TypicallyacommentwasnotedinthemedicalCurrent Gerontology and Geriatrics Research 5
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Figure 1: A Kaplan-Meier survival analysis stratiﬁed by age of
cumulative incidence of cataracts for participants with Down
syndrome.
record that the condition was in the early stages and was
not suﬃciently advanced to warrant surgery, along with
a recommendation for reexamination to evaluate disease
progression. Cataract surgery was reported for a relatively
small number of individuals with the condition, 15.6%. For
11% of adults with Down syndrome, a change in eyeglass
prescription was ordered at the time of diagnosis. The
medical charts of 22.9% of individuals did not specify any
treatment at the time of diagnosis.
3.3. Eﬀects of Ophthalmic Disorders on Cognitive and
Adaptive/Behavioral Function. To determine the impact of
ophthalmic disorders on adaptive behavior and cognition,
individuals with and without ophthalmic disorder(s) were
compared on a number of performance measures dependent
on visual processing (AAMR Adaptive Behavior Scale, the
Block Design Test, and the Beery-Buktenica Developmental
Test of Visual-Motor Integration) and those that were
independent of visual processing (the Verbal Fluency Test
and the Selective Reminding Test). Table 4 presents the
means for these measures as a function of ophthalmic status.
We excluded cases where blepharitis, conjunctivitis, and/or
dry eye were the only conditions reported, reasoning that
they do not usually cause impairment in visual functioning.
An analysis of covariance was conducted where ophthalmic
status (with and without an ophthalmic disorder(s)) was the
between-subjects measure and IQ was the covariate. (The
number of participants that completed each test diﬀered
between tests and therefore degrees of freedom varied as
Table 4: Adjusted least square means and standard errors for adap-
tive behavior and cognitive measures as a function of ophthalmic
status.
Performance measure
With
ophthalmic
disorders
Without
ophthalmic
disorders
Functions dependent on visual
processing
AAMR-Adaptive Behavior Scale 169.12 (2.73) 179.81 (4.63)
Block Design Test 10.09 (.50) 12.71 (.79)
Beery-Buktenica Developmental Test
of Visual-Motor Integration 8.28 (.24) 9.19 (.39)
Functions independent on visual
processing
Selective Reminding Test 23.11 (.82) 24.03 (1.27)
Verbal Fluency Test 5.66 (.24) 5.68 (.24)
well.) In adults with Down syndrome, scores on measures
that relied on visual processing were related to overall
ophthalmic status, although the eﬀect sizes were small
(AAMR Adaptive Behavior Scale, F (1,425) = 3.95, P =
.048, Cohen’s d  = .193; the Block Design Test, F (1,322) =
7.84, P = .005, Cohen’s d  = .312; the Beery-Buktenica
Developmental Test of Visual-Motor Integration, F (1,338) =
3.95, P = .048, Cohen’s d  = .216). We next examined the
eﬀects of speciﬁc ophthalmic disorders expected to have the
most substantial eﬀects on quality of life. Being legally blind
had a detrimental eﬀect on adaptive behavior, visuospatial
organization, and construction ability although the eﬀect
sizesweresmall(AAMRAdaptiveBehaviorScale,F (1,425) =
4.28, P = .039, Cohen’s d  = .201; the Block Design Test,
F (1,322) = 4.23, P = .041, Cohen’s d  = .229; the Beery-
Buktenica Developmental Test of Visual-Motor Integration,
F (1,338) = 4.10, P = .044, Cohen’s d  = .220). Having
cataracts also had a detrimental eﬀect on performance
(AAMR Adaptive Behavior Scale, F (1,425) = 20.44, P<
.001, Cohen’s d  = .439; the Block Design Test, F (1,322) =
20.78, P<. 001, Cohen’s d  = .508; the Beery-Buktenica
Developmental Test of Visual-Motor Integration, F (1,338) =
12.55, P<. 001, Cohen’s d  = .385). Individuals with
presbyopia, astigmatism, myopia, or strabismus performed
comparablyonallmeasurescomparedtoindividualsthatdid
nothavetheseconditions.Fortasksthatwereindependentof
visual processing, the performance of individuals with and
without an ophthalmic disorder and with or without any of
the above speciﬁc ophthalmic conditions was comparable.
4. Discussion
The examination of medical records has shown that adults
with Down syndrome are at an increased risk for ophthalmic
disorders with advancing age. The chances of having at least
one ophthalmic disorder increased signiﬁcantly with age and
older participants had a greater number of these disorders
thanyoungerparticipants.Itwasalsoclearthatinadultswith
Down syndrome, speciﬁc ophthalmic disorders are closely
related to the age of the individual. We found that while6 Current Gerontology and Geriatrics Research
astigmatism and refractive errors were more prevalent in
younger individuals, cataracts and blepharitis were more
common in older individuals.
Contrary to previous studies, the prevalence of oph-
thalmic disorders was unrelated to severity of intellectual
disability, with the one exception being that individuals
who were legally blind were more likely to have profound
intellectual disability. Given that visual processing is a
relative strength for individuals with Down syndrome, this
ﬁnding may reﬂect atypically severe consequences of visual
impairment on cognitive development, but at this point it
seems clear that valid interpretation will be dependent upon
further investigation.
Cataracts were the most prevalent ophthalmic disorder
recorded in medical charts for participants. As expected,
prevalence increased with advancing age, and our data indi-
cates that individuals with Down syndrome were signiﬁ-
cantly younger than individuals in the general population
at the time of diagnosis [49]. This was consistent with an
extensive body of literature documenting that people with
Down syndrome show some signs of accelerated biological
aging (e.g., [3, 51–53]). At the time of initial diagnosis,
generally no treatment was prescribed for adults with Down
syndrome and cataract surgery was reported infrequently.
Many of the medical charts included a note that the
condition was mild at the time of diagnosis and did not
require treatment. We could not ﬁnd comparable data on
treatment prescribed at the time of diagnosis for adults
in the general population, but further monitoring without
immediate treatment is an accepted option within standard
clinical practice.
As found in other studies, blepharitis and conjunctivitis,
both inﬂammatory conditions of the eye, were found to be
common conditions in individuals with Down syndrome.
Blepharitis may be related to the narrow, slanted palpebral
ﬁssures characteristic in individuals with Down syndrome
[54] or an increased susceptibility to infection associated
with the impact of trisomy 21 on the immune system [22,
55, 56].
Severe visual impairment in adults without intellectual
disability is known to negatively interfere with the ability
to perform activities of daily living, especially those that
rely on vision [57]. For example, diﬃculty with mobility
[58, 59] and sleep problems [60] have been reported for
older adults with low vision or blindness. Concerns about
general safety may also come into play [53]. In individuals
with intellectual disability, Evenhuis et al. [33]c o n c l u d e d
that visual impairment compounds preexisting disability.
We observed that in individuals with Down syndrome
ophthalmic disorder(s) negatively aﬀected adaptive behavior
and cognitive functions that rely on visual processing. This
was in contrast to the ﬁnding that individuals with and
without ophthalmic disorder(s) performed comparably on
selected skills that were independent of visual functioning
(e.g.,episodicmemoryandverbalﬂuency).Wealsoobserved
that not all ophthalmic disorders were equally detrimental to
adaptive behavior or cognition. Being legally blind had the
most serious impact on participants’ adaptive behavior skills
and cognitive functioning, as one would expect, and having
cataractsproved alsotobedetrimental. However, individuals
with ophthalmic disorders were not aﬀected to the extent
that we expected. It is possible that ophthalmic disorders are
being detected and treated appropriately in this population
to a greater extent than previously supposed (cf. [61]), at
least within networks serving our study participants.
An important limitation of the present analysis is the
reliance on data from medical charts. Medical charts can
be inaccurate or incomplete compared to direct examina-
tion. For example, charts frequently made no mention of
treatments prescribed for ophthalmic conditions, but that
could be either because no treatments were provided or no
notation of provided treatments were made.
Our results have important implications with respect to
the ophthalmic care of adults with Down syndrome. The
high prevalence of ophthalmic disorders highlights the need
for periodic evaluations of adults with Down syndrome to
identify age-related changes and other pathological eye con-
ditions. In an IASSID International Consensus Statement,
Evenhuis and Nagtzaam [62] proposed that planned vision
screening and examinations for adults with Down syndrome
should begin by age 30 and be conducted at least every
ﬁve years. Pueschel et al. [63] and Van Buggenhout et al.
[27] alternatively recommend more frequent assessments, at
least every 2 years in adult patients with Down syndrome
and increasing in frequency with advancing age. The present
ﬁndings conﬁrm the need for regular eye examinations, and
the possibility of impaired vision needs to be investigated
whenever declines in functional abilities occur in an older
adult with Down syndrome.
Appendix
Deﬁnitions of Ophthalmic Terms
Amblyopia (Lazy Eye): Poor vision in one or both eyes that
is not associated with any speciﬁc pathology and that persists
after the correction of refractive errors.
Aphakia: Absence of the lens of the eye due either to surgical
removal, a perforating wound or ulcer, or a congenital
abnormality.
Astigmatism: Unequal curvatures along the diﬀerent merid-
ians in one or more of the refractive surfaces of the eye.
Blepharitis: Chronic inﬂammation of the eyelids.
Cataract: Acloudingofthecrystallinelensoftheeyevarying
from a mild to complete opacity and resulting in the
obstruction of the passage of light.
Conjunctivitis: Acute inﬂammation of the conjunctiva, the
outermostlayeroftheeyeandtheinnersurfaceoftheeyelids.
It is most commonly caused by an allergic reaction or an
infection.
Cornea: The clear front window of the eyeball.Current Gerontology and Geriatrics Research 7
Diabetic Retinopathy: A condition, which causes progressive
damage to the blood vessels of the retina resulting from
complications of diabetes mellitus.
Dry Eye Syndrome (Keratitis Sicca): Chronic lack of lubrica-
tion and moisture in the eye.
Esotropia: Af o r mo fs t r a b i s m u si nw h i c ho n eo rb o t he y e s
turns inward.
Exotropia: Af o r mo fs t r a b i s m u si nw h i c ho n eo rb o t he y e s
are deviated outward. It is the opposite of esotropia.
Glaucoma: A group of diseases that damage the optic nerve
and results in progressive and irreversible vision loss and
blindness. It is frequently, although not always, associated
with increased ﬂuid pressure of the eye.
Hyperopia (Farsightedness): A refractive defect of the eye
whereby near objects appear blurred because the image is
focused in back of the retina rather than directly on it.
Keratoconus: A degenerative noninﬂammatory disorder of
the eye in which structural changes within the corneal curve
cause it to thin and subsequently to deform the shape of
the cornea to a more conical shape from its normal gradual
curve.
Myopia (Nearsightedness): A refractive defect of the eye
whereby distant objects appear blurred because an image is
focused in front of the retina, in the vitreous, rather than on
it.
Nystagmus: Refers to the rhythmic, repetitive, oscillating,
involuntary eye movements that occur when a large portion
of the visual ﬁeld moves constantly in a horizontal direction
and can contribute to decreased vision. The movements
consist of a slow phase in which the moving ﬁeld is tracked
(smooth pursuit), followed by a rapid “return” movement
(saccade); this pattern is repeated until the ﬁeld stops
moving. In pathological cases, nystagmus can occur in the
absence of a moving stimulus.
Optic Neuritis: Is an inﬂammation of the optic nerve that
may result in a complete or partial loss of vision.
Presbyopia: Is the progressively diminishing ability to focus
on nearby objects resulting from the loss of elasticity of the
crystalline lens that occurs with advancing age.
Pseudoaphakia: A congenital condition in which the crys-
talline lens has degenerated and been replaced by mesoder-
mal tissue.
Pterygium: Refers to a triangular thickening of the conjunc-
tiva (outer coating of the eye) that grows onto the cornea
causing redness, irritation, and tearing. If it grows large
enough, it may interfere with vision.
Ptosis: Drooping of the upper eyelid in one or both eyes
caused when the muscles that raise the eyelid (levator and
M¨ uller’s muscle’s) are not strong enough to do so properly.
RefractiveErrors: Errorsinthefocusingoflight,forexample,
myopia.
Retinal Detachment: A disorder of the eye in which the inner
layers of the retina separate from the underlying layer of
supportive tissue, the retinal pigment epithelium.
Retinitis Pigmentosa: A group of inheritable degenerative
retinal diseases in which abnormalities of the photoreceptors
(the rods and cones) or the retinal pigment epithelium led to
progressive and incurable vision loss.
Strabismus: A condition in which the eyes are not properly
aligned with each other. When looking at an object, the
images do not fall on corresponding retinal locations.
Visual Acuity: Refers to a measure of the spatial resolving
capacity of the visual system.
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